Novo Nordisk
NVO
#27
Rank
โ‚น30.942 T
Marketcap
โ‚น6,880
Share price
-9.43%
Change (1 day)
-36.65%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚น1.249 Trillion

According to Novo Nordisk's latest financial reports the company's total debt is โ‚น1.249 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2024-12-31โ‚น1.230 T269.51%
2023-12-31โ‚น332.96 B8.37%
2022-12-31โ‚น307.25 B1.76%
2021-12-31โ‚น301.94 B141.18%
2020-12-31โ‚น125.19 B161.19%
2019-12-31โ‚น47.93 B768.78%
2018-12-31โ‚น5.51 B-68.36%
2017-12-31โ‚น17.43 B691.39%
2016-12-31โ‚น2.20 B-78.91%
2015-12-31โ‚น10.44 B40.21%
2014-12-31โ‚น7.45 B203.07%
2013-12-31โ‚น2.45 B-49.34%
2012-12-31โ‚น4.85 B-38.25%
2011-12-31โ‚น7.86 B-55.8%
2010-12-31โ‚น17.78 B43.36%
2009-12-31โ‚น12.40 B-40.79%
2008-12-31โ‚น20.95 B99.81%
2007-12-31โ‚น10.48 B-11.82%
2006-12-31โ‚น11.89 B-37.99%
2005-12-31โ‚น19.17 B42.54%
2004-12-31โ‚น13.45 B0.86%
2003-12-31โ‚น13.34 B38.01%
2002-12-31โ‚น9.66 B-18.3%
2001-12-31โ‚น11.83 B-1.14%
2000-12-31โ‚น11.96 B-5.44%
1999-12-31โ‚น12.65 B-25.72%
1998-12-31โ‚น17.03 B-3.85%
1997-12-31โ‚น17.72 B47.65%
1996-12-31โ‚น12.00 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น5.546 T 343.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.931 T 134.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.461 T 256.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.623 T 29.92%๐Ÿ‡ซ๐Ÿ‡ท France